Hematopoietic Cell Transplantation After Nonmyeloablative Conditioning for Advanced Chronic Lymphocytic Leukemia
Mohamed L. Sorror(University of Washington Medical Center), David G. Maloney(Fred Hutch Cancer Center), Monic J. Stuart(United States Department of Veterans Affairs), Benedetto Bruno(Azienda Ospedaliera Citta' della Salute e della Scienza di Torino), Thomas R. Chauncey(City Of Hope National Medical Center), Amelia Langston(CancerCare Manitoba), Haifa Kathrin Al‐Ali(University Hospital in Halle), Michael R. Loken(Unknown), Barry E. Storer(City Of Hope National Medical Center), Ute Hegenbart(Heidelberg University), Brenda M. Sandmaier(University of Washington), Rainer Storb(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Jerald P. Radich(University of Washington), Peter A. McSweeney(Mesoblast (United States)), Edward Agura(Baylor University), Karl G. Blume(City Of Hope National Medical Center), Michael B. Maris(Colorado Blood Cancer Institute), Michael A. Pulsipher(Primary Children's Hospital), José F. Leis(Mayo Clinic), Christopher Bredeson
Cited by 231
Related Papers
Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma
|New England Journal of Medicine|2017|6k
Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
|New England Journal of Medicine|2018|5.7k
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
|Blood|2022|2.8k
Chronic graft-versus-host syndrome in man
|The American Journal of Medicine|1980|2.4k